|Wednesday, 13 December 2017 07:06|
Type 2 Diabetes Mellitus Forecast at 22 Big Markets 2018-2028 – Research and Markets
This report provides the present prevalent population for type 2 diabetes mellitus across 22 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Sweden, Denmark, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by sex and 5-year era cohort. Along with the prevalence, the report contains a disease overview of these risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Supplying a value-added degree of insight in several of co-morbidities and the symptoms of type 2 diabetes mellitus, some individual parameters and features, in addition to the analysis group have been quantified and presented alongside the total figures. These sub-populations within the disease are contained in a country level across the 10-year prediction photo.
Main symptoms and co-morbidities for type 2 diabetes mellitus include:
Key Issues Covered:
Source: Research and Markets
BiomedReports is not paid or paid from newswires to disseminate or report information and developments about publicly traded firms, but can from time to time receive compensation for advertising, data, analytics and investor relation services from several entities and firms. Full disclosures should be read in the ‘Around Us Section’.
Add this page to a Social Bookmarking sites